BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
SDEV
Stablecoin Development Corp.
There isn't enough reported data to score SDEV yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SDEV Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SDEV's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SDEV.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | โ |
| Current | 12x | $50.51 | โ |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
SDEV PE Valuation
SDEV has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SDEV Forward outlook
There aren't enough analyst estimates for SDEV to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus SDEV down 99%.
SDEV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | $2.30 | +$419.08 |
| Q2 2025 | $0.40 | +$478.93 |
| Q1 2025 | -$4.80 | +$689.13 |
| Q4 2024 | -$38.15 | +$778.28 |
| Q3 2024 | -$416.78 | +$929.13 |
| Q3 2021 | -$918.75 | +$1,286.25 |
| Q2 2021 | -$1,102.50 | +$735.00 |
| Q1 2021 | -$1,776.25 | $0.00 |
SDEV has returned to profit: it earned $2.30 per share over the past year, after losing money the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 7.3% for SDEV.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
SDEV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1M | +311% |
| Q3 2025 | $521K | -79% |
| Q4 2024 | $2.3M | -38% |
| Q3 2024 | $2.4M | -25% |
| Q2 2024 | $2.4M | -48% |
| Q1 2024 | $2.6M | -16% |
| Q4 2023 | $3.7M | +2.3% |
| Q3 2023 | $3.3M | -15% |
SDEV's revenue has slid since its 2023 peak: $2M last quarter, down 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2615% | +2856 points |
| Q2 2026 | -2441% | N/A |
| Q1 2026 | 905% | N/A |
| Q3 2025 | -241% | -198 points |
| Q4 2024 | -56% | +35 points |
| Q3 2024 | -43% | -9.3 points |
| Q2 2024 | -44% | -15 points |
| Q1 2024 | -93% | -37 points |
SDEV has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over SDEV on cash generation, producing positive trailing cash flow while its opponent burns cash.
SDEV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | +$720K |
| Q2 2026 | -$6M | -$3M |
| Q1 2026 | -$1.8M | -$480K |
| Q4 2025 | -$2.3M | -$1.3M |
| Q3 2025 | -$1.8M | +$223K |
| Q2 2025 | -$3M | -$2.4M |
| Q1 2025 | -$1.3M | +$250K |
| Q4 2024 | -$972K | -$656K |
SDEV's free cash flow was โ$11M over the past year, against โ$7M the year before. Free cash flow isn't a meaningful measure for financial services companies like SDEV.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SDEV Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SDEV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 1.7 | Oversold |
SDEV's weekly RSI is 45 (neutral) and its Stochastic is 2 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
SDEV PE vs Financial Services Sector
| Metric | SDEV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
SDEV has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over SDEV on trend strength, trading above more of its moving averages.
SDEV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.90 | 59% below |
| 20 week MA | $1.42 | 45% below |
| 50 week MA | $7.30 | 89% below |
| 100 week MA | $5.88 | 87% below |
| 200 week MA | $47.6 | 98% below |
SDEV is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over SDEV on returns for 2026, with the stronger performance.
SDEV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4,026.6 | $4,471.3 | +11% |
| 2021 | $4,471.3 | $2,686.4 | -40% |
| 2022 | $2,686.4 | $248.5 | -91% |
| 2023 | $248.5 | $35.7 | -86% |
| 2024 | $35.7 | $2.88 | -92% |
| 2025 | $2.88 | $24.3 | +742% |
| 2026 YTD | $24.3 | $0.78 | -97% |
SDEV's yearly returns have swung widely, from +742% in 2025 to โ92% in 2024. It's down 97% so far in 2026.